Monografie
Defective Mitochondria Contribute to Impaired Translation in Spinal Muscular Atrophy
- Sprache
-
Englisch
- Identifier
-
1236691520
- Thema
-
Mitochondria; Spinal muscular atrophy
- Beteiligte Personen und Organisationen
-
Thelen, Maximilian Paul
Wirth, Brunhilde
Rugarli, Elena I.
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:57 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Monografie
Beteiligte
- Thelen, Maximilian Paul
- Wirth, Brunhilde
- Rugarli, Elena I.
Ähnliche Objekte (12)
Impaired dynamic interaction of axonal endoplasmic reticulum and ribosomes contributes to defective stimulus-response in spinal muscular atrophy
Plastin 3 rescues defective cell surface translocation and activation of TrkB in mouse models for spinal muscular atrophy
Diagnosis and management of spinal muscular atrophy : : Part 2
Molecular mechanisms underlying defective axonal growth and presynaptic differentiation in spinal muscular atrophy = Entstehungsmechanismen gestörten Axonwachstums und präsynaptischer Differenzierung bei spinaler Muskelatrophie
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
Costs of illness of spinal muscular atrophy: a systematic review
Cytoskeletal dysregulation in the motoneuron disease Spinal Muscular Atrophy (SMA)
Molecular mechanisms of cytoskeletal dysregulations in Spinal Muscular Atrophy (SMA)
J wave syndromes in patients with spinal and bulbar muscular atrophy
Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes
Development of antisense oligonucleotide combinatorial therapies for spinal muscular atrophy (SMA)
Novel modifiers for inherited neurodegenerative disorders : spinal muscular atrophy and ataxia
Impaired dynamic interaction of axonal endoplasmic reticulum and ribosomes contributes to defective stimulus-response in spinal muscular atrophy
Plastin 3 rescues defective cell surface translocation and activation of TrkB in mouse models for spinal muscular atrophy
Diagnosis and management of spinal muscular atrophy : : Part 2
Molecular mechanisms underlying defective axonal growth and presynaptic differentiation in spinal muscular atrophy = Entstehungsmechanismen gestörten Axonwachstums und präsynaptischer Differenzierung bei spinaler Muskelatrophie
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
Costs of illness of spinal muscular atrophy: a systematic review
Cytoskeletal dysregulation in the motoneuron disease Spinal Muscular Atrophy (SMA)
Molecular mechanisms of cytoskeletal dysregulations in Spinal Muscular Atrophy (SMA)
J wave syndromes in patients with spinal and bulbar muscular atrophy
Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes
Development of antisense oligonucleotide combinatorial therapies for spinal muscular atrophy (SMA)
Novel modifiers for inherited neurodegenerative disorders : spinal muscular atrophy and ataxia
Impaired dynamic interaction of axonal endoplasmic reticulum and ribosomes contributes to defective stimulus-response in spinal muscular atrophy
Plastin 3 rescues defective cell surface translocation and activation of TrkB in mouse models for spinal muscular atrophy
Diagnosis and management of spinal muscular atrophy : : Part 2
Molecular mechanisms underlying defective axonal growth and presynaptic differentiation in spinal muscular atrophy = Entstehungsmechanismen gestörten Axonwachstums und präsynaptischer Differenzierung bei spinaler Muskelatrophie
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
Costs of illness of spinal muscular atrophy: a systematic review
Cytoskeletal dysregulation in the motoneuron disease Spinal Muscular Atrophy (SMA)
Molecular mechanisms of cytoskeletal dysregulations in Spinal Muscular Atrophy (SMA)
J wave syndromes in patients with spinal and bulbar muscular atrophy
Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes
Development of antisense oligonucleotide combinatorial therapies for spinal muscular atrophy (SMA)